Aquatic high intensity training for chronic heart failure patients
Effect of Aquatic High Intensity Resistive Training on Cardiac Function and Exercise Capacity in Patients With Chronic Heart Failure
This study is testing whether a special water workout can help people with chronic heart failure feel stronger and improve their heart health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 45 Years to 60 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Dokki) |
| Trial ID | NCT06297707 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of aquatic high intensity resistive training on cardiac function and exercise capacity in patients with chronic heart failure. A total of 60 participants will be randomly assigned to either an experimental group, which will undergo supervised aquatic resistance training three times a week for 12 weeks, or a control group that will continue their usual care. The training will involve progressive resistance exercises in a heated pool, focusing on maximizing muscle contraction while ensuring safety and proper movement. The study aims to assess improvements in exercise tolerance and overall cardiac health.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 45 to 60 with chronic heart failure classified as NYHA class I to III and a left ventricular ejection fraction greater than 50%.
Not a fit: Patients with acute heart failure, severe arrhythmias, or other significant comorbidities that limit exercise will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance exercise capacity and quality of life for patients with chronic heart failure.
How similar studies have performed: While aquatic training has been explored in various contexts, this specific approach focusing on high intensity resistive training in heart failure patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Age ranges from 45 to 60 years old. Have chronic heart failure (NYHA class I to III). * Left ventricular ejection fraction (LVEF) \> 50% * clinically stable with optimal pharmacological therapy in greater than three months * All patients didn't participate in any rehabilitation programs prior to the study. Exclusion Criteria: Signs of acute heart failure, unstable angina, or severe arrhythmia three months prior to enrolment in the study. Pacemakers. recently diagnosed acute coronary syndrome or a recent coronary intervention or both renal insufficiency (estimated glomerular filtration rate \< 30 mL/min) liver abnormalities uncontrolled hypertension moderate-to-severe valvular disease uncompensated heart failure patients Chronic lung disease. Other disorders counteracting exercise conditions that limit lower limb mobility (for example, burns, fractures)
Where this trial is running
Cairo, Dokki
- Faculty of Physical Therapy — Cairo, Dokki, Egypt (Recruiting)
Study contacts
- Principal investigator: marwa elsayed — Cairo University
- Study coordinator: marwa elsayed, PhD
- Email: marwa.elsaid@cu.edu.eg
- Phone: 0201156033818
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.